
Browsing restrictions can be lifted for a fee.
2.81%
National health investors, inc.
-0.38%
Avg of Sector
-0.31%
S&P500

Browsing restrictions can be lifted for a fee.
| Quarterly | EPS Forecast | QoQ | Max | Min |
|---|---|---|---|---|
| 2026Q1 | ||||
| 2026Q2 | ||||
| 2026Q3 | ||||
| 2026Q4 | ||||
| 2027Q1 |
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2025Q4 | |||||||
| 2025Q3 | |||||||
| 2025Q2 | |||||||
| 2025Q1 |
The most recent financial report for National health investors, inc. (NHI) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating NHI's short-term business performance and financial health. For the latest updates on NHI's earnings releases, visit this page regularly.
According to historical valuation range analysis, National health investors, inc. (NHI)'s current price-to-earnings (P/E) ratio is 29.89, placing it in the Watch zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
According to the latest financial report, National health investors, inc. (NHI) reported an Operating Profit of 50.3M with an Operating Margin of 47.53% this period, representing a growth of 19.03% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, National health investors, inc. (NHI) announced revenue of 105.82M, with a Year-Over-Year growth rate of 23.4%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
As of the end of the reporting period, National health investors, inc. (NHI) had total debt of 1.16B, with a debt ratio of 0.42. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
At the end of the period, National health investors, inc. (NHI) held Total Cash and Cash Equivalents of 19.62M, accounting for 0.01 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, National health investors, inc. (NHI) achieved the “three margins increasing” benchmark, with a gross margin of 77.9%%, operating margin of 47.53%%, and net margin of 36%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess NHI's profit trajectory and future growth potential.
According to the past four quarterly reports, National health investors, inc. (NHI)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.8. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
National health investors, inc. (NHI)'s Free Cash Flow (FCF) for the period is 57.62M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 176.11% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
The latest valuation data shows National health investors, inc. (NHI) has a Price-To-Earnings (PE) ratio of 29.89 and a Price/Earnings-To-Growth (PEG) ratio of 1.47. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.